Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.060
+0.050 (1.66%)
At close: Apr 2, 2026, 4:00 PM EDT
3.100
+0.040 (1.31%)
After-hours: Apr 2, 2026, 7:53 PM EDT

Exagen Revenue

In the year 2025, Exagen had annual revenue of $66.58M with 19.65% growth. Exagen had revenue of $16.63M in the quarter ending December 31, 2025, with 21.79% growth.

Revenue (ttm)
$66.58M
Revenue Growth
+19.65%
P/S Ratio
1.11
Revenue / Employee
$302,614
Employees
220
Market Cap
73.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202566.58M10.93M19.65%
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 201832.44M5.63M21.01%
Dec 31, 201726.81M8.86M49.38%
Dec 31, 201517.95M6.28M53.87%
Dec 31, 201411.66M8.61M281.77%
Dec 31, 20133.06M2.13M229.91%
Dec 31, 2012926.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
Fulgent Genetics322.67M
MDxHealth107.88M
FONAR106.03M
Prenetics Global92.39M
Biodesix88.50M
Burning Rock Biotech77.14M
Precipio24.05M
Revenue Rankings